Key result
Laparoscopic sleeve gastrectomy yields ~40% complete diabetes remission at one year in class II obesity.
Why the study?
Does laparoscopic sleeve gastrectomy combined with medical management improve metabolic indices and induce remission of Type 2 Diabetes Mellitus in non-morbidly obese patients?
Cohort (n=15)
No
Does laparoscopic sleeve gastrectomy combined with medical management improve metabolic indices and induce remission of Type 2 Diabetes Mellitus in non-morbidly obese patients?
Laparoscopic sleeve gastrectomy combined with medical management significantly improves weight and glycemic control, leading to diabetes remission in a majority of non-morbidly obese patients with uncontrolled T2DM.
Answers are grounded in this paper and cite their sources.
May support diabetes remission after sleeve gastrectomy in class II obesity; leaves open need for randomized trials before practice change.
BACKGROUND: Type 2 diabetes mellitus (T2DM) and obesity are often associated in the same metabolic pathology and represent a significant public health problem. Although laparoscopic sleeve gastrectomy (LSG) is a relatively recent technique of bariatric surgery, it has shown to be efficient and safe and has obtained much support from physicians and patients. Several studies have highlighted the effects in terms of resolution and improvement of diabetes. SUBJECTS AND METHODS: From January 2009 to November 2012, 15 patients in Obesity Class II (body mass index [BMI], 37.9 ± 1.5 kg/m(2); baseline weight, 102.7 ± 11.6 kg) with uncontrolled T2DM despite taking a glucose-lowering drug therapy (glycated hemoglobin [HbA1c], 8.1 ± 0.6%) underwent LSG and advanced practice medical management in accordance with the American Diabetes Association guidelines. All patients were subjected to follow-up controls with anthropometric and metabolic indices at 5, 15, 30, and 60 days, and at 6 and 12 months after surgery, remission of diabetes was also evaluated. RESULTS: At 1 year after surgery, the mean excess weight loss percentage (EWL%) was 58.4%, and the mean BMI had decreased from the preoperative value of 37.9 kg/m(2) to 30.4 kg/m(2). The average reduction in HbA1c was 2.5 (30.9%). The mean homeostatic model assessment of insulin resistance decreased from 13.3 to 4.9. Overall, during the period of observation, four patients (26.7%) had started drug therapy again, six patients had complete remission (40%), and five patients had partial remission (33.3%). CONCLUSIONS: LSG not only makes it possible to attain a significant EWL% in obese patients, but also a remission or improvement of diabetes. Further studies are required to determine the duration of the effect and the role of different factors involved.
No takes yet. Share an insight, caveat, or question.
Desiderio et al. (2013) conducted a cohort in Type 2 Diabetes Mellitus (n=15). Laparoscopic sleeve gastrectomy and medical management was evaluated on complete remission of diabetes. Laparoscopic sleeve gastrectomy in patients with Obesity Class II and uncontrolled type 2 diabetes resulted in complete diabetes remission in 40% and partial remission in 33.3% at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: